Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. reports on treasury share and ADR transactions for the month of May 2016, filed on June 10, 2016. The report complies with Article 11 of CVM Instruction # 358/2002 regarding securities and derivatives operations.
Key Financial Metrics
The filing details specific treasury stock movements rather than consolidated financial performance metrics such as revenue or profit.
- Treasury Shares (Common): Initial balance of 19,211,405 shares; Final balance of 19,517,097 shares.
- Treasury ADRs: Initial balance of 0; Final balance of 0.
- Total Buy Volume (Common Shares): 908,934 shares acquired via the Plan of Shares Acquisition.
- Total Buy Volume (ADRs): 76,455 ADRs acquired via the Plan of Shares Acquisition.
- Total Sell Volume (Common Shares): 524,625 shares sold via option exercises.
- Total Sell Volume (ADRs): 155,072 ADRs sold via option exercises and bonuses.
Material Changes
During the reporting period, the company executed a net increase in its treasury share position.
- Net Treasury Change: The company purchased 908,934 common shares and sold 524,625 common shares, resulting in a net increase of 384,309 treasury shares.
- ADR Conversions: 78,617 common shares were converted into ADRs, and 78,617 ADRs were subsequently converted back or offset, resulting in no net change to the ADR treasury balance.
- Transaction Types: Activity included direct conversions, option exercises, and purchases under the Plan of Shares Acquisition.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly a regulatory disclosure of specific securities transactions.
Investor Verification Checklist
- Verify the impact of the 384,309 net increase in treasury shares on the company's total outstanding share count.
- Confirm the pricing of the "Plan of Shares Acquisition" transactions (ranging from R$ 18.40 to R$ 19.60) against market prices for May 2016.
- Review the option exercise prices (ranging from R$ 2.04 to R$ 9.36) to assess the dilution effect relative to the buyback program.
- Check subsequent filings for the final disposition of the ADRs converted during the period.